Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients

Ähnliche Einträge

• Changes in glomerular filtration rate in liver recipients after reduced exposure to calcineurin inhibitors with concomitant everolimus administration within the first year after immunosuppression conversion
  von: V. E. Syutkin, et al.
  Veröffentlicht: (2022-01-01)
• Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
  von: M. Sh. Khubutia, et al.
  Veröffentlicht: (2016-01-01)
• The effect of early everolimus administration on the renal function while reducing the dosage of calcineurin inhibitors in liver transplant recipients in a long-term follow-up
  von: V. E. Syutkin, et al.
  Veröffentlicht: (2021-06-01)
• Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
  von: V. E. Syutkin, et al.
  Veröffentlicht: (2021-09-01)
• Successful liver transplantation in critically ill patient (Case report)
  von: M. Sh. Khubutia, et al.
  Veröffentlicht: (2016-01-01)